Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
30.4
% (change in net income attributable to owners of the parent)Wording
Definitive
How definitive the wording is.Revised forecast
Fiscal year ended June 2024 · Full yearPrevious forecast published 9 February 2024Net Sales110,000→115,434million
+4.9%
Operating profit10,500→13,382million
+27.5%
Ordinary income10,500→13,559million
+29.1%
Profit attributable to owners of the parent7,500→9,781million
+30.4%
Net income per share271.08→353.54yen and sen
+30.4%
The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Reason for the revision
パッケージングプラント事業で飲料用無菌充填システムの生産が想定以上に進捗し、メカトロシステム事業で医療機器の海外向けが増加した。利益面では、案件の工事進捗、改造工事の増加、社内プロジェクトによるコスト削減、付加価値の高い製品の割合増加により売上原価が改善した。
Previous-period results売上高97,842百万円、営業利益8,039百万円、経常利益8,171百万円、親会社株主に帰属する当期純利益5,928百万円、１株当たり当期純利益214.29円 銭（2023年6月期）
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | ¥110,000 million → ¥115,434 million（+4.9%） |
| Operating profit | ¥10,500 million → ¥13,382 million（+27.5%） |
| Ordinary income | ¥10,500 million → ¥13,559 million（+29.1%） |
| Profit attributable to owners of the parent | ¥7,500 million → ¥9,781 million（+30.4%） |
| Net income per share | 271.08 yen and sen → 353.54 yen and sen |
| Fiscal Period Covered | Fiscal year ended June 2024 |
| Period Covered | Full year |
| Publication date of previous forecast | 9 February 2024 |
| Previous-period results | 売上高97,842百万円、営業利益8,039百万円、経常利益8,171百万円、親会社株主に帰属する当期純利益5,928百万円、１株当たり当期純利益214.29円 銭（2023年6月期） |
| Reason for the revision | パッケージングプラント事業で飲料用無菌充填システムの生産が想定以上に進捗し、メカトロシステム事業で医療機器の海外向けが増加した。利益面では、案件の工事進捗、改造工事の増加、社内プロジェクトによるコスト削減、付加価値の高い製品の割合増加により売上原価が改善した。 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
Details and amount of extraordinary lossDividend forecast revision
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.パッケージングプラント事業で飲料用無菌充填システムの生産が想定以上に進捗し、メカトロシステム事業で医療機器の北米・インドなど海外向けが増加した。利益面では、他社製品の割合が低い案件の工事進捗、客先の新製品対応の改造工事の増加、社内プロジェクトによるコスト削減効果、付加価値の高い製品の割合増加により売上原価が改善した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.